Cargando…
Identifying patients who will not reachieve remission after breakthrough seizures
OBJECTIVE: We aim to identify people with epilepsy who are unlikely to reachieve a 12‐month remission within 2 years after experiencing a breakthrough seizure following an initial 12‐month remission. METHODS: We apply a novel longitudinal discriminant approach to data from the Standard and New Antie...
Autores principales: | Hughes, David M., Bonnett, Laura J., Marson, Anthony G., García‐Fiñana, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487810/ https://www.ncbi.nlm.nih.gov/pubmed/30900756 http://dx.doi.org/10.1111/epi.14697 |
Ejemplares similares
-
Identification of patients who will not achieve seizure remission within 5 years on AEDs
por: Hughes, David M., et al.
Publicado: (2018) -
Breakthrough seizures—Further analysis of the Standard versus New Antiepileptic Drugs (SANAD) study
por: Bonnett, Laura J., et al.
Publicado: (2017) -
Risk of a seizure recurrence after a breakthrough seizure and the implications for driving: further analysis of the standard versus new antiepileptic drugs (SANAD) randomised controlled trial
por: Bonnett, L J, et al.
Publicado: (2017) -
Breakthrough SARS‐CoV‐2 infections in immune mediated disease patients undergoing B cell depleting therapy: A retrospective cohort analysis
por: Calabrese, Cassandra M, et al.
Publicado: (2022) -
Anti-Seizure Activity of 1-Adamantane Carboxylic Acid in Common Experimental Seizure Models: Role of Benzodiazepine-GABA(A) Receptors
por: Ghanbari, Elham, et al.
Publicado: (2021)